Search Results - "Sokoll, Kenneth K"
-
1
Using Flash Nanoprecipitation To Produce Highly Potent and Stable Cellax Nanoparticles from Amphiphilic Polymers Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel
Published in Molecular pharmaceutics (06-11-2017)“…We report the use of flash nanoprecipitation (FNP) as an efficient and scalable means of producing Cellax nanoparticles. Cellax polymeric conjugates consisting…”
Get full text
Journal Article -
2
Nanoparticle Formulation Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel for Chemotherapy Delivery to the Brain
Published in Bioconjugate chemistry (20-06-2018)“…Nanoparticles provide a unique opportunity to explore the benefits of selective distribution and release of cancer therapeutics at sites of disease through…”
Get full text
Journal Article -
3
Site-specific UBITh® amyloid-β vaccine for immunotherapy of Alzheimer's disease
Published in Vaccine (20-04-2007)“…Abstract The UBITh® AD immunotherapeutic vaccine for Alzheimer's disease uses an amyloid-β (Aβ) immunogen having two designer peptides that have been…”
Get full text
Journal Article Conference Proceeding -
4
Abstract 1687: A novel PKC inhibitor: Inhibition of cell proliferation in cancer cell lines and pharmacokinetics in Sprague-Dawley rats
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Abstract Background: Cancer treatment by conventional chemotherapy is hindered by toxic side effects and the frequent development of multi-drug resistance by…”
Get full text
Journal Article -
5
Abstract 2907: Novel liposomal compositions of PharmaGap's lead peptide: Effect on ovarian cancer cell proliferation and signaling pathways
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract Background: Liposomes, vesicular structures in the nano - micrometer range, have been widely studied as drug delivery vehicles. Liposomes can…”
Get full text
Journal Article -
6
Site-specific UBITh®amyloid-[beta] vaccine for immunotherapy of Alzheimer's disease
Published in Vaccine (20-04-2007)“…The UBITh®AD immunotherapeutic vaccine for Alzheimer's disease uses an amyloid-β (Aβ) immunogen having two designer peptides that have been engineered to…”
Get full text
Journal Article